20-5578575-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000379019.7(GPCPD1):c.510C>T(p.Asp170=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00986 in 1,612,208 control chromosomes in the GnomAD database, including 147 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0093 ( 13 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 134 hom. )
Consequence
GPCPD1
ENST00000379019.7 synonymous
ENST00000379019.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.74
Genes affected
GPCPD1 (HGNC:26957): (glycerophosphocholine phosphodiesterase 1) Predicted to enable glycerophosphocholine phosphodiesterase activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within skeletal muscle tissue development. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 20-5578575-G-A is Benign according to our data. Variant chr20-5578575-G-A is described in ClinVar as [Benign]. Clinvar id is 780073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.74 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPCPD1 | NM_019593.5 | c.510C>T | p.Asp170= | synonymous_variant | 8/20 | ENST00000379019.7 | NP_062539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPCPD1 | ENST00000379019.7 | c.510C>T | p.Asp170= | synonymous_variant | 8/20 | 1 | NM_019593.5 | ENSP00000368305 | P1 | |
GPCPD1 | ENST00000481038.5 | n.1918C>T | non_coding_transcript_exon_variant | 3/15 | 2 | |||||
GPCPD1 | ENST00000481690.2 | c.*128C>T | 3_prime_UTR_variant, NMD_transcript_variant | 7/8 | 3 | ENSP00000488635 |
Frequencies
GnomAD3 genomes AF: 0.00930 AC: 1415AN: 152112Hom.: 13 Cov.: 32
GnomAD3 genomes
AF:
AC:
1415
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00977 AC: 2457AN: 251394Hom.: 28 AF XY: 0.00957 AC XY: 1300AN XY: 135872
GnomAD3 exomes
AF:
AC:
2457
AN:
251394
Hom.:
AF XY:
AC XY:
1300
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00992 AC: 14480AN: 1459978Hom.: 134 Cov.: 31 AF XY: 0.00990 AC XY: 7191AN XY: 726420
GnomAD4 exome
AF:
AC:
14480
AN:
1459978
Hom.:
Cov.:
31
AF XY:
AC XY:
7191
AN XY:
726420
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00930 AC: 1415AN: 152230Hom.: 13 Cov.: 32 AF XY: 0.0104 AC XY: 777AN XY: 74432
GnomAD4 genome
AF:
AC:
1415
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
777
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 03, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at